BioMap
PrivateLast Round
IPO
Mar 16, 2026
Total Funding Raised
$100M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioMap is a biotechnology company that develops AI foundation models for life sciences to accelerate drug discovery and biological research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioMap Comparables
Compare BioMap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 85% | |
| Generate Biomedicines | 85% | |
| Chai Discovery | 84% | |
BioMap Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 16, 2026 | ||||
| VC Round | Jun 24, 2024 | ||||
| Series A | Jul 30, 2021 |
BioMap Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hong Kong Investment Corporation | VC Round |
| Lanchi Ventures | Series A |
| Legend Capital | Series A |
| BlueRun Ventures | Series A |
| Xiang He Capital | Series A |
| GGV Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Completed an IPO round.
- Mar 17, 2025
Launched xTrimo V3, a multimodal foundation model for life sciences.
BioMap Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioMap's valuation, stock price, and market status.